Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide

Journal of Controlled Release

Volumn 162, Issue 3, 2012, Pages 521-528

  He, Xiaofeng ^a   Bonaparte, Napolean ^a   Kim, Soyoun ^a   Acharya, Bodhraj ^a   Lee, Ji Young ^a   Chi, Lianhua ^a   Lee, Hyoung Joo ^b   Paik, Young Ki ^b   Moon, Pyong Gon ^a   Baek, Moon Chang ^a   Lee, Eun Kyu ^c   Kim, Jong Ho ^d   Kim, In San ^a   Lee, Byung Heon ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Gachon University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Apoptosis; Biological anchor for membrane; Chemotherapy; Peptide; T cell delivery

Indexed keywords

ACID DERIVATIVE; ANTIGEN PRESENTATION; APOPTOTIC; CANCER IMMUNOTHERAPY; IN-VIVO; LIVING CELL; MEMBRANE ANCHORING; NOVEL STRATEGIES; PEPTIDE LIGAND; T CELLS; TUMOR CELLS;

BODY FLUIDS; CELL MEMBRANES; CHEMOTHERAPY; DEGRADATION; PEPTIDES; TUMORS;

CELL DEATH;

DOXORUBICIN; LIGAND; PROTEIN APOPEP 1 BIOCOMPATIBLE ANCHOR FOR MEMBRANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL HOMING; CELL MEMBRANE; CELL THERAPY; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE DELIVERY; TUMOR CELL;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL MEMBRANE; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE; NEOPLASMS; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; T-LYMPHOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84865609692     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.07.023     Document Type: Article

References (35)

1. C.H. June Adoptive T cell therapy for cancer in the clinic J. Clin. Invest. 117 2007 1466 1476
2. A.A. Chekmasova, and R.J. Brentjens Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer Discov. Med. 9 2010 62 70
3. S.A. Rosenberg, N.P. Restifo, J.C. Yang, R.A. Morgan, and M.E. Dudley Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat. Rev. Cancer 8 2008 299 308
4. B.A. Guinn, N. Kasahara, F. Farzaneh, N.A. Habib, J.S. Norris, and A.B. Deisseroth Recent advances and current challenges in tumor immunology and immunotherapy Mol. Ther. 15 2007 1065 1071
5. L. Gattinoni, S.E. Finkelstein, C.A. Klebanoff, P.A. Antony, D.C. Palmer, P.J. Spiess, L.N. Hwang, Z. Yu, C. Wrzesinski, D.M. Heimann, C.D. Surh, S.A. Rosenberg, and N.P. Restifo Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells J. Exp. Med. 202 2005 907 912
6. M.T. Stephan, J.J. Moon, S.H. Um, A. Bershteyn, and D.J. Irvine Therapeutic cell engineering with surface-conjugated synthetic nanoparticles Nat. Med. 16 2010 1035 1041
7. L. Zhang, S.P. Kerkar, Z. Yu, Z. Zheng, S. Yang, N.P. Restifo, S.A. Rosenberg, and R.A. Morgan Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment Mol. Ther. 19 2011 751 759
8. D.M. Kranz, T.A. Patrick, K.E. Brigle, M.J. Spinella, and E.J. Roy Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis Proc. Natl. Acad. Sci. U. S. A. 92 1995 9057 9061
9. R.C. Grabert, L.P. Cousens, J.A. Smith, S. Olson, J. Gall, W.B. Young, P.A. Davol, and L.G. Lum Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation Clin. Cancer Res. 12 2006 569 576
10. M.H. Kershaw, J.A. Westwood, L.L. Parker, G. Wang, Z. Eshhar, S.A. Mavroukakis, D.E. White, J.R. Wunderlich, S. Canevari, L. Rogers-Freezer, C.C. Chen, J.C. Yang, S.A. Rosenberg, and P. Hwu A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer Clin. Cancer Res. 12 2006 6106 6115
11. C.H. Lamers, S. Sleijfer, A.G. Vulto, W.H. Kruit, M. Kliffen, R. Debets, J.W. Gratama, G. Stoter, and E. Oosterwijk Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience J. Clin. Oncol. 24 2006 e20 e22
12. L.A. Emens Chemotherapy and tumor immunity: an unexpected collaboration Front. Biosci. 13 2008 249 257
13. N. Casares, M.O. Pequignot, A. Tesniere, F. Ghiringhelli, S. Roux, N. Chaput, E. Schmitt, A. Hamai, S. Hervas-Stubbs, M. Obeid, F. Coutant, D. Metivier, E. Pichard, P. Aucouturier, G. Pierron, C. Garrido, L. Zitvogel, and G. Kroemer Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death J. Exp. Med. 202 2005 1691 1701
14. S.R. Mattarollo, T. Kenna, M. Nieda, and A.J. Nicol Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity Cancer Immunol. Immunother. 56 2007 1285 1297
15. A.K. Nowak, R.A. Lake, A.L. Marzo, B. Scott, W.R. Heath, E.J. Collins, J.A. Frelinger, and B.W. Robinson Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells J. Immunol. 170 2003 4905 4913
16. M. Obeid, A. Tesniere, F. Ghiringhelli, G.M. Fimia, L. Apetoh, J.L. Perfettini, M. Castedo, G. Mignot, T. Panaretakis, N. Casares, D. Metivier, N. Larochette, P. van Endert, F. Ciccosanti, M. Piacentini, L. Zitvogel, and G. Kroemer Calreticulin exposure dictates the immunogenicity of cancer cell death Nat. Med. 13 2007 54 61
17. C.K. Song, H.D. Han, K.H. Noh, T.H. Kang, Y.S. Park, J.H. Kim, E.S. Park, B.C. Shin, and T.W. Kim Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus Mol. Ther. 15 2007 1558 1563
18. S. Demaria, M.D. Volm, R.L. Shapiro, H.T. Yee, R. Oratz, S.C. Formenti, F. Muggia, and W.F. Symmans Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy Clin. Cancer Res. 7 2001 3025 3030
19. V.A. Fadok, D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J. Immunol. 148 1992 2207 2216
20. S.J. Gardai, K.A. McPhillips, S.C. Frasch, W.J. Janssen, A. Starefeldt, J.E. Murphy-Ullrich, D.L. Bratton, P.A. Oldenborg, M. Michalak, and P.M. Henson Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte Cell 123 2005 321 334
21. M. Radic, T. Marion, and M. Monestier Nucleosomes are exposed at the cell surface in apoptosis J. Immunol. 172 2004 6692 6700
22. D. Wu, A. Ingram, J.H. Lahti, B. Mazza, J. Grenet, A. Kapoor, L. Liu, V.J. Kidd, and D. Tang Apoptotic release of histones from nucleosomes J. Biol. Chem. 277 2002 12001 12008
23. K. Wang, S. Purushotham, J.Y. Lee, M.H. Na, H. Park, S.J. Oh, R.W. Park, J.Y. Park, E. Lee, B.C. Cho, M.N. Song, M.C. Baek, W. Kwak, J. Yoo, A.S. Hoffman, Y.K. Oh, I.S. Kim, and B.H. Lee In vivo imaging of tumor apoptosis using histone H1-targeting peptide J. Control. Release 148 2010 283 291
24. K. Wang, M.H. Na, A.S. Hoffman, G. Shim, S.E. Han, Y.K. Oh, I.C. Kwon, I.S. Kim, and B.H. Lee In situ dose amplification by apoptosis-targeted drug delivery J. Control. Release 154 2011 214 217
25. S.Y. Hwang, Y. Cho do, H.K. Kim, S.H. Cho, J. Choo, W.J. Yoon, and E.K. Lee Preparation of targeting proteoliposome by postinsertion of a linker molecule conjugated with recombinant human epidermal growth factor Bioconjug. Chem. 21 2010 345 351
26. K. Kato, C. Itoh, T. Yasukouchi, and T. Nagamune Rapid protein anchoring into the membranes of mammalian cells using oleyl chain and poly(ethylene glycol) derivatives Biotechnol. Prog. 20 2004 897 904
27. S.A. Yoo, D.G. Bae, J.W. Ryoo, H.R. Kim, G.S. Park, C.S. Cho, C.B. Chae, and W.U. Kim Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes J. Immunol. 174 2005 5846 5855
28. C.L. van Broekhoven, C.R. Parish, G. Vassiliou, and J.G. Altin Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development J. Immunol. 164 2000 2433 2443
29. S.H. Jang, M.G. Wientjes, and J.L. Au Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule J. Pharmacol. Exp. Ther. 296 2001 1035 1042
30. A. Boissonnas, L. Fetler, I.S. Zeelenberg, S. Hugues, and S. Amigorena In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor J. Exp. Med. 204 2007 345 356
31. M. Edinger, Y.A. Cao, M.R. Verneris, M.H. Bachmann, C.H. Contag, and R.S. Negrin Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging Blood 101 2003 640 648
32. M.J. Pittet, J. Grimm, C.R. Berger, T. Tamura, G. Wojtkiewicz, M. Nahrendorf, P. Romero, F.K. Swirski, and R. Weissleder In vivo imaging of T cell delivery to tumors after adoptive transfer therapy Proc. Natl. Acad. Sci. U. S. A. 104 2007 12457 12461
33. P. Mrass, H. Takano, L.G. Ng, S. Daxini, M.O. Lasaro, A. Iparraguirre, L.L. Cavanagh, U.H. von Andrian, H.C. Ertl, P.G. Haydon, and W. Weninger Random migration precedes stable target cell interactions of tumor-infiltrating T cells J. Exp. Med. 203 2006 2749 2761
34. O. Kepp, L. Galluzzi, I. Martins, F. Schlemmer, S. Adjemian, M. Michaud, A.Q. Sukkurwala, L. Menger, L. Zitvogel, and G. Kroemer Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy Cancer Metastasis Rev. 30 2011 61 69
35. Y. Ma, R. Conforti, L. Aymeric, C. Locher, O. Kepp, G. Kroemer, and L. Zitvogel How to improve the immunogenicity of chemotherapy and radiotherapy Cancer Metastasis Rev. 30 2011 71 82